Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
52,033,500 shares traded today and the share price still struggles to close at .0045? What is the problem here?
PLAINTIFF REQUEST FOR PRODUCTION
Reset Original Sort Link To Activity Code Docket Date P/D Docket Entry Ver
1 REPR 01/21/2011 PLAINTIFF REQUEST FOR PRODUCTION F
CBAI is trading at .0042, the market has all the links and information it needs.
"Maybe that's why CBAI is having a tough time getting funding Imo."
maybe- perhaps; possibly
Imo- in my opinion
Why would the CEO lie about immediately needing $14,000,000 in the 12/8/10 8-K if DWHP (as some say) is in the picture to help CBAI financially?
"Is that an Offer to Loan us Money" Does CBAI have any collateral or assets not already held or spoken for by JMJ Financial or other note holders? Maybe that's why CBAI is having a tough time getting funding Imo.
Agreed, the 12/8/10 8-K says Matt needs $14,000,000 immediately.
"the requirement that Cord Blood immediately raise privately, additional capital estimated by management to approximate $14 Million, in order to fund the cash payments required to close the transaction. There is no assurance that Cord Blood will be successful in raising such additional capital, or raising it in a timely fashion or under commercially reasonable terms."
http://www.sec.gov/Archives/edgar/data/1289496/000135448810003802/cbai_8k.htm
Matt having any luck with the $14,000,000 CBAI needs? I see that "CEO Matthew Schissler called in from Hong Kong and reported on the company's Chinese interests."
Doesn't Matt hold positions at companies other than CBAI? Pyrenees and the milk business and CBA properties at minimum. Maybe Mr. Talavera has other places of employment as well.
It doesn't make sense for CCEL to waste time deposing a janitor at Cryo-Cell Mexico. Probably something very important or revealing that Mr. Talavera had to say under oath.
Looks like CCEL got a Cryo-Cell Mexico insider to sign a sworn affidavit under oath Imo.
Affidavit of Omar Villasenor Talavera filed by CCEL
1 AFFD 01/20/2011 PLAINTIFF AFFIDAVIT OF OMAR VILLASENOR TALAVERA F
2 FILE 01/20/2011 PLAINTIFF NOTICE OF FILING AFFIDAVIT F
3 MLAW 01/20/2011 PLAINTIFF MEMORANDUM OF LAW IN SUPPORT EMERGENCY MOTION F
Yes, Matt is a real genius, CBAI started out with a 50M O/S or less since inception now the O/S is 5,600,000,000+ and still needs $14,000,000 to close the deal in Mexico.
Someone posted CBAI's all time high share price was $1.50 now it's a third of a penny, yes Matt's a genius.
"Well, all I'm thinking is if Matt and company (including his lawyers) ever thought or knew they were doing something illegal when they made the bids for CCEL, they would be the absolute dumbest people in the world to just all of a sudden blurt it out in court for all to hear! Don't you think? I have to think Matt is a little smarter than that."
Well, for example, Enron, World Com, Tyco, all had smart lawyers too.
Yes, amended case NOT a dismissed case. Agreed.
The case WAS NOT dismissed. Just as I suspected and now the docket proves it. Somebody lied.
You have a point Pit, but what if CCEL was just as surprised by all this DW/CBAI stuff and found out about it on 1/14/11 in open court? There was nothing in DW's letters to CCEL saying CBAI was involved:
DWHP Withdraws Second Offer for CCEL - Based on Board's Refusal to Engage in Discussions
PARK CITY, Utah, Oct. 15 /PRNewswire/ -- DW Healthcare Partners, LP (DWHP), a healthcare focused private equity firm with over $250 million in committed capital under management, today responded to the refusal of the board of directors of Cryo-Cell International, Inc. to engage in discussions regarding DWHP's all-cash offers to acquire the issued and outstanding Cryo-Cell shares at substantial premiums to market value. Given the Cryo-Cell board's refusal to meet with DWHP regarding the proposed transaction, DWHP has withdrawn its latest offer, which represented a 94% premium from CCEL's share price prior to DWHP's first offer.
"We are very disappointed that Cryo-Cell's board not only rejected our offer, but refused to even meet with us. We offered Cryo-Cell shareholders a substantial premium to the current stock price, as well as full liquidity in a thinly traded-stock. The board's refusal to engage in discussions regarding our offer raises serious concerns about the board's priorities. Our all-cash offer is extremely positive for Cryo-Cell shareholders. We note, in fact, that the shareholders appear to agree with our position, given the significant increase in the Cryo-Cell stock price since we made our initial offer. As such, we believe the board should have addressed our offer with Cryo-Cell shareholders. Given the board's refusal to engage in discussions with us, we have withdrawn our offer," said Andrew Carragher, Co-Founder and Managing Director of DWHP.
The following table sets forth the particulars of DWHP's offers to the Cryo-Cell board:
Date
DWHP
Closing
DWHP
Premium to Share Price
Offer
Price
Premium
at Original Offer
9/9/2010
$1.50
$0.90
67%
67%
9/27/2010
$1.75
$1.50
17%
94%
A copy of DWHP's latest offer, dated September 27, 2010, follows:
September 27, 2010
Mercedes Wilson
Chair of the Board and Chief Executive Officer
Cryo-Cell International, Inc.
700 Brooker Creek Boulevard
Suite 1800
Oldsmar, Florida 34677
Dear Mercedes:
We were extremely disappointed to receive your September 9th letter reporting the decision of the Cryo-Cell board to reject our August 30th offer without engaging in any discussions regarding the proposed transaction. We find it surprising that your board would simply reject a cash offer representing a 67% premium to the share price the day of our original offer. We are also disappointed that you have been unwilling to return my phone calls or engage in any dialogue regarding a possible transaction. Those actions do not appear to be in the best interests of Cryo-Cell stockholders, and raise significant concerns regarding your board's attention to its fiduciary duties to those stockholders – particularly in light of the public backlash by many shareholders about management and the stock's poor performance in recent years.
Notwithstanding your refusal to engage in discussions regarding the proposed transaction, we remain convinced that our offer represents the best option for the Cryo-Cell stockholders, allowing them to not only achieve full liquidity on a very thinly traded stock, but also a substantial premium to the current share price. Although we believe our original offer was favorable to Cryo-Cell stockholders, we are prepared to increase the amount of our offer, in an attempt to facilitate dialogue with you and the Cryo-Cell board regarding the proposed transaction.
This letter confirms our revised offer to acquire all of the outstanding shares of Cryo-Cell common stock at a purchase price of $1.75 per share in cash. The following table shows the significant premium offered by DWHP on a per share basis.
Date
DWHP
Closing
DWHP
Premium to Share Price
Offer
Price
Premium
at Original Offer
9/9/2010
$1.50
$0.90
67%
67%
9/27/2010
$1.75
$1.50
17%
94%
Our revised offer increases the premium to 94% over the closing price of the Cryo-Cell stock on the day of our original offer.
We hope you and the Cryo-Cell board will respond positively to our revised offer. As I indicated in our prior correspondence, we are prepared to fund the transaction through available equity capital from our existing DWHP Fund II, and the proposed transaction would not be subject to any type of financing contingency. Our proposal remains subject to reaching a mutually satisfactory definitive acquisition agreement and our completion of a satisfactory due diligence review. We would like to commence the due diligence and negotiation of an acquisition agreement as soon as possible.
We look forward to commencing a productive dialogue with you regarding the proposed transaction. Please contact me as promptly as possible to confirm your willingness to proceed with substantive discussions by 5:00 p.m. Eastern Time on Thursday, September 30, 2010.
Sincerely yours,
Andrew Carragher
Co-Founder and Managing Director
DW Healthcare Partners, LP
1413 Center Drive., Suite 220
Park City, Utah 84098
(435) 645-4053 – office
(435) 640-3543 – mobile
andrew@dwhp.com
CC: Ki Yong Choi, Scott Christian, Andrew J. Filipowski, Anthony P. Finch, Michael W. Cho, Sung Won Sohn,
"There is nothing illegal about how Matt is/was trying to acquire Cyro-Cell International or Cyro Cell Mexico."
That remains to be seen, this CCEL and CBAI thing is far from being over with. I hope it works out well for you.
So your answer is no, there were not 2 publicly traded companies involved and not under further scrutiny by the SEC, thanks for your honest reply.
Were they 2 publicly traded companies involved like CBAI and CCEL where the SEC might raise some eyebrows?
"I personally have bought 3 business in the past using other peoples money. Those other people are called INVESTORS! In two of the instances, the investor was the one who made the offers on my behalf that were eventually accepted."
Now that Matt allegedly admitted in open court on Friday January 14, 2011 in a hearing held at the Pinellas County FL courthouse that he tried unsuccessfully on 2 seperate occasions to purchase CCEL under what appears to be false pretenses (not disclosing CBAI was the true purchaser), I wonder if CCEL will seek any legal sanctions either civil or criminal against CBAI in the future?
False Pretense;
False representation of fact or circumstance, calculated to mislead
DWHP Withdraws Second Offer for CCEL - Based on Board's Refusal to Engage in Discussions
PARK CITY, Utah, Oct. 15 /PRNewswire/ -- DW Healthcare Partners, LP (DWHP), a healthcare focused private equity firm with over $250 million in committed capital under management, today responded to the refusal of the board of directors of Cryo-Cell International, Inc. to engage in discussions regarding DWHP's all-cash offers to acquire the issued and outstanding Cryo-Cell shares at substantial premiums to market value. Given the Cryo-Cell board's refusal to meet with DWHP regarding the proposed transaction, DWHP has withdrawn its latest offer, which represented a 94% premium from CCEL's share price prior to DWHP's first offer.
"We are very disappointed that Cryo-Cell's board not only rejected our offer, but refused to even meet with us. We offered Cryo-Cell shareholders a substantial premium to the current stock price, as well as full liquidity in a thinly traded-stock. The board's refusal to engage in discussions regarding our offer raises serious concerns about the board's priorities. Our all-cash offer is extremely positive for Cryo-Cell shareholders. We note, in fact, that the shareholders appear to agree with our position, given the significant increase in the Cryo-Cell stock price since we made our initial offer. As such, we believe the board should have addressed our offer with Cryo-Cell shareholders. Given the board's refusal to engage in discussions with us, we have withdrawn our offer," said Andrew Carragher, Co-Founder and Managing Director of DWHP.
The following table sets forth the particulars of DWHP's offers to the Cryo-Cell board:
Date
DWHP
Closing
DWHP
Premium to Share Price
Offer
Price
Premium
at Original Offer
9/9/2010
$1.50
$0.90
67%
67%
9/27/2010
$1.75
$1.50
17%
94%
A copy of DWHP's latest offer, dated September 27, 2010, follows:
September 27, 2010
Mercedes Wilson
Chair of the Board and Chief Executive Officer
Cryo-Cell International, Inc.
700 Brooker Creek Boulevard
Suite 1800
Oldsmar, Florida 34677
Dear Mercedes:
We were extremely disappointed to receive your September 9th letter reporting the decision of the Cryo-Cell board to reject our August 30th offer without engaging in any discussions regarding the proposed transaction. We find it surprising that your board would simply reject a cash offer representing a 67% premium to the share price the day of our original offer. We are also disappointed that you have been unwilling to return my phone calls or engage in any dialogue regarding a possible transaction. Those actions do not appear to be in the best interests of Cryo-Cell stockholders, and raise significant concerns regarding your board's attention to its fiduciary duties to those stockholders – particularly in light of the public backlash by many shareholders about management and the stock's poor performance in recent years.
Notwithstanding your refusal to engage in discussions regarding the proposed transaction, we remain convinced that our offer represents the best option for the Cryo-Cell stockholders, allowing them to not only achieve full liquidity on a very thinly traded stock, but also a substantial premium to the current share price. Although we believe our original offer was favorable to Cryo-Cell stockholders, we are prepared to increase the amount of our offer, in an attempt to facilitate dialogue with you and the Cryo-Cell board regarding the proposed transaction.
This letter confirms our revised offer to acquire all of the outstanding shares of Cryo-Cell common stock at a purchase price of $1.75 per share in cash. The following table shows the significant premium offered by DWHP on a per share basis.
Date
DWHP
Closing
DWHP
Premium to Share Price
Offer
Price
Premium
at Original Offer
9/9/2010
$1.50
$0.90
67%
67%
9/27/2010
$1.75
$1.50
17%
94%
Our revised offer increases the premium to 94% over the closing price of the Cryo-Cell stock on the day of our original offer.
We hope you and the Cryo-Cell board will respond positively to our revised offer. As I indicated in our prior correspondence, we are prepared to fund the transaction through available equity capital from our existing DWHP Fund II, and the proposed transaction would not be subject to any type of financing contingency. Our proposal remains subject to reaching a mutually satisfactory definitive acquisition agreement and our completion of a satisfactory due diligence review. We would like to commence the due diligence and negotiation of an acquisition agreement as soon as possible.
We look forward to commencing a productive dialogue with you regarding the proposed transaction. Please contact me as promptly as possible to confirm your willingness to proceed with substantive discussions by 5:00 p.m. Eastern Time on Thursday, September 30, 2010.
Sincerely yours,
Andrew Carragher
Co-Founder and Managing Director
DW Healthcare Partners, LP
1413 Center Drive., Suite 220
Park City, Utah 84098
(435) 645-4053 – office
(435) 640-3543 – mobile
andrew@dwhp.com
CC: Ki Yong Choi, Scott Christian, Andrew J. Filipowski, Anthony P. Finch, Michael W. Cho, Sung Won Sohn,
Oh! Now I get it, CBAI wanted to buy CCEL under false pretenses Imo and CBAI currently has the $14,000,000 it needs to buy Cryo-Cell Mexico. Yes, You are correct!!! GO CBAI!!! WEEEEEEEEEEEEEEEEEEEEEEEEEEEEEE!!!!!!!!!!
Your reply was to me sir. I doubt Matt has DW behind him otherwise why say in the 12/8/10 8-K that he immediately needed $14,000,000 and in the 12/16/10 "Clear Path To Profitability" radio interview he said he "was currently working on it" trying to get funding. Why would Matt lie about needing money if "He does have HUGE money behind him in DW."
Agree with you, if I had close contact with Matt and knew everything was under control at CBAI, there would be no need for me to be so nervous. All I would have to do is sit back and relax and wait for the big pop. Apparently something is wrong here Imo.
News of a reverse split or share increase is probably on the way Imo judging by the way the mm's have been acting lately.
CBAI is grossly overvalued Imo, and their value will be further diminished if the proposed increase in authorized shares goes through.
Comparing CBAI's 9 month 2010 revenues of $2,749,353 to CCEL's $13,079,047 we can all see why CBAI is so desperate to make something happen.
How can Cryo-Cell Mexico be a "Major Part" of CCEL when Cryo-Cell Mexico is responsible for bringing in $639,000 compared to CCEL's total revenues of $13,079,047 for the nine months ended August 31, 2010?
Travel and talk, what else does CBAI have to show for itself?
No no no! Matt Schissler said CASE DISMISSED the time to celebrate is now!!! Case Dismissed means CASE DISMISSED!!! I am not crazy, I am not delusional, the CEO said CASE DISMISSED!!!! The CEO has never been wrong and has ALWAYS delivered on what he said in PR's!!!! WEEEEEEEEEEEEEEEEE!!!!!!!!
Yes! CASE DISMISSED!!! It's over for CCEL!!!
Lets all do the Hey Macarena!!!!!!! WEEEEEEEEEEEEEEEEEEEEEEEEEEEEEE!!!!!!!
No! CASE DISMISSED!!! All legal action has CEASED!!! CBAI wins!!!!!
WEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEE!!!!!!!!!!!!!
"CASE DISMISSED From Matt Schissler The case was dismissed and injunction not granted. That's the technical result. The Plaintiff is allowed for file an amendment to the case and resubmit. But todays case is officially dismissed. We did set a new hearing date, but that is only if the defendant does file that amendment in the stated time frame, which would... trigger a new case. The date for the new trial would be the 25th of February if the plaintiff does file the amendment.
See More "
Oh, Now I get it, 100% proof CASE DISMISSED! Here it is right here in the docket from Pinellas Court! Yes! once again you are correct!!! GO CBAI! WEEEEEEEEEEEEEEEEEEEEEEEE!!!!!!!!!!
1NOTH 01/11/2011 DEFENDANT NOTICE OF HEARING 011411 9:00 F
2MEOT 01/11/2011 DEFENDANT AMENDED MEMORANDUM IN OPPOSITION TO: EMERGENCY MOTN F
3AMED 01/11/2011 DEFENDANT AMENDED MOTN DISMISS FAILURE TO JOIN INDISPENDSIBLE PARTY F
Oh! Now I get it, CBAI hasn't won the lawsuit brought on by CCEL after all and further proceedings are still pending! Dang it! weeeeeeeeeeeeeeeeeeeeeeeee?????????
Oh! Now I get it, CBAI has already won the lawsuit brought on by CCEL and there aren't any additional hearings scheduled and the Pinellas Court docket has shown the case has been completley dismissed! Yes! You are correct! GO CBAI! WEEEEEEEEEEEEEEEEEEE!!!!!!!!!!!!!!
It could be short sellers loading up on the bid waiting for a big drop from the lawsuit outcome.
"Of all the pennies out there, I have never seen one hold so solid in the face of a lawsuit."
Oh! Now I get it, CBAI had DWHP in their pocket since September of 2010 but Matt needlessly stated in a 8-K dated 12/8/10 that CBAI immediately needed $14,000,000 and raise the authorized shares to close the Mexico deal. Yes! You are correct! CBAI already has the money! WEEEEEEEEEEEEEEEEE!!!!!!!!!!!!
Any signs of the company getting the $14,000,000 it needs to close the Mexico deal? I think the halfway mark of the 90 day period is today.
Yippeee! CBAI will be trading 3 cents per share before the market closes today! WEEEEEEEEEEEEEEE!!!!!!!!
"If so" I'll be sure to take a tour of CBAI headquarters located at 1857 Helm Drive, Las Vegas NV and say hello.
Oh! Now I get it, the case against CBAI has no merit and CCEL might as well not waste any more money on attorney fees and let CBAI have their way. Case is closed, CBAI wins!!!!!! WEEEEEEEEEEEEEE!!!!!!!!!!!
Some were saying the case would get thrown out today. They must be disappointed right now. So sad.